Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 18th Mar 2014 08:58

Antofagasta: Investec places its target price (prev.: 753p) under review, while leaving its sell recommendation unchanged.Ashtead Group: Credit Suisse raises target price from 1000p to 1100p and stays with its outperform rating. UBS increases target price from 875p to 1020p retaining its buy recommendation.ASOS: Panmure Gordon raises target price from 6051p to 6126p and leaves its hold recommendation unaltered.BAE Systems: RBC Capital ups target price from 450p to 490p and upgrades to outperform.Berkeley Group: Numis raises target price to 3000p and upgrades from hold to add.Bioquell: Investec lowers target price from 147p to 133p and stays with its hold recommendation.Bunzl: JP Morgan shifts target price from 1516p to 1520p and reiterates a neutral rating.Capital Drilling: Liberum Capital moves target price from 35p to 40p and stays with its buy recommendation.Close Brothers Group: JP Morgan increases target price from 1480p to 1512p and stays with its overweight rating.CSR: UBS raises target price from 580p to 750p, while its neutral rating remains unchanged.Exillon Energy: Investec places both its target price (prev.: 270p) and its buy recommendation under review.Glencore Xstrata: RBC Capital ups target price from 350p to 375p and leaves its outperform rating unchanged.Great Portland Group: UBS raises target price from 670p to 705p leaving its buy recommendation unaltered.Gulf Keystone Petroleum: Cantor Fitzgerald cuts target price from 183p to 154p and maintains a buy recommendation.Hikma Pharmaceuticals: Bank of America raises target price from 1600p to 1750p staying with its neutral rating.IG Group: Canaccord Genuity takes target price from 666p to 711p and retains a buy recommendation.Japan Residential Investment: Liberum Capital lowers target price from 74p to 68p and leaves its buy recommendation unchanged.Mears Group: Investec increases target price from 495p to 520p and retains an add rating.Mecom: Numis shifts target price from 150p to 155p and keeps a buy recommendation. Canaccord Genuity shifts target price from 150p to 158p maintaining a buy recommendation.Pearson: Numis reduces target price from 1189p to 1048p and leaves its hold recommendation unaltered.Pittards: WH Ireland ups target price from 230p to 270p and keeps a buy recommendation.Premier Foods: UBS takes target price from 65p to 115p, but still recommends selling.Redefine International: Deutsche Bank moves target price from 38.3p to 51p, but downgrades to hold.Royal Bank of Scotland: RBC Capital reduces target price from 310p to 250p and keeps its underperform rating.RSA Insurance: Berenberg cuts target price from 112p to 92.6p retaining its hold recommendation.Sainsbury: JP Morgan reduces target price from 340p to 280p and stays with its underweight rating. Panmure Gordon cuts target price from 400p to 320p retaining its hold recommendation.Schroders: Credit Suisse raises target price from 2810p to 2900p reiterating its neutral rating.SDL: Panmure Gordon moves target price from 410p to 421p maintaining a buy recommendation. Canaccord Genuity increases target price from 266p to 325p retaining a hold recommendation.Shore Capital: RBC Capital raises target price from 300p to 450p and maintains its outperform rating.SIG: Deutsche Bank shifts target price from 182p to 190p reiterating its hold recommendation.Spirax-Sarco Engineering: Investec reduces target price from 3425p to 3210p, while keeping its buy recommendation.TUI Travel: Barclays ups target price from 445p to 500p reiterating an overweight rating.UNITE: Jefferies raises target price from 465p to 497p and retains a buy recommendation.
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.